RetinalGenix Technologies (RTGN) Cash from Operations (2020 - 2026)
RetinalGenix Technologies (RTGN) posted Cash from Operations of 109213.0 for Q1 2026, up 14.82% sequentially from 128219.0 in Q4 2025, and up 41.67% YoY from 77091.58 in Q1 2025.
RetinalGenix Technologies (RTGN) Cash from Operations (2020 - 2026) Analysis & Trends
RetinalGenix Technologies has reported Cash from Operations for 7 years, with the latest figure at 109213.0 in Q1 2026.
- Quarterly Cash from Operations rose 41.67% year-over-year to 109213.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 480341.0 (up 37.24% YoY) and the FY2025 annual result came in at 558350.0, up 24.74% from the prior year.
- Cash from Operations climbed to 109213.0 in Q1 2026 per RTGN's latest filing, from 128219.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 39749.0 in Q3 2023 and troughed at 290025.0 in Q4 2023.
- A 5-year average of 121202.76 and a median of 123810.0 in 2023 frame the typical range for Cash from Operations.
- The widest YoY moves for Cash from Operations: up 167.42% in 2023, down 1100.41% in 2023.
- Over 5 years, Cash from Operations stood at 33225.0 in 2022, then plunged by 772.91% to 290025.0 in 2023, then soared by 35.73% to 186390.0 in 2024, then surged by 31.21% to 128219.0 in 2025, then increased by 14.82% to 109213.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 109213.0, 128219.0, and 103837.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.75 Bn | 194.14 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Stryker | 127.36 Bn | 123.88 Bn | 4.50 Bn | 1.26 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 73.20 Bn | 72.66 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.10 Bn | 47.85 Bn | 1.35 Bn | 651.90 Mn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 269.20 Mn |
| 7 | GE HealthCare Technologies | 33.77 Bn | 31.66 Bn | 2.18 Bn | 168.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 437.05 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 367.10 Mn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | -109,213.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -109,213.00 |
| Mar 31, 2026 | -109,213.00 |
| Dec 31, 2025 | -128,219.00 |
| Dec 31, 2025 | -128,219.00 |
| Sep 30, 2025 | -103,837.00 |
| Sep 30, 2025 | -103,837.00 |
| Jun 30, 2025 | -139,072.00 |
| Jun 30, 2025 | -139,072.00 |
| Mar 31, 2025 | -187,222.00 |
| Mar 31, 2025 | -187,222.00 |
| Dec 31, 2024 | -186,390.00 |
| Dec 31, 2024 | -186,390.00 |
| Sep 30, 2024 | -246,932.00 |
| Sep 30, 2024 | -246,932.00 |
| Jun 30, 2024 | -144,795.00 |
| Jun 30, 2024 | -144,795.00 |
| Mar 31, 2024 | -163,819.00 |
| Mar 31, 2024 | -163,819.00 |
| Dec 31, 2023 | -290,025.00 |
| Dec 31, 2023 | -290,025.00 |